SGS Pharma

SGS Pharma Clinical Research is a leading CRO (contract service organization) offering clinical research and bioanalytical testing with a specific focus on early stage development and biometrics (phase I to IV).  

Visit Website

Locations

  • APAC
  • Europe
  • North America

Therapeutic Areas

  • Bone / Osteoporosis
  • Cardiovascular
  • CNS
  • Dermatology
  • Diabetes
  • Endocrinology
  • Gastroenterology
  • Genetic Diseases
  • Hematology
  • Hepatology
  • Immunology
  • Infectious Diseases
  • Inflammation
  • Internal Diseases
  • Metabolic Diseases
  • Musculoskeletal
  • Nephrology
  • Neurology
  • Nutrition and Health
  • Obstetrics / Gynecology
  • Oncology
  • Ophthalmology
  • Other
  • Pediatrics / Neonatology
  • Pharmacology / Toxicology
  • Psychiatry
  • Pulmonary
  • Rare Disease
  • Respiratory
  • Rheumatology
  • Thrombosis
  • Urology
  • Vaccines
  • Women's Health

SGS Pharma Clinical Research is a leading CRO specializing in early-stage development and functional biometrics (Phases I–IV).

With a strong presence in Europe and the Americas, SGS offers a comprehensive range of clinical trial services, including full early-phase drug development consultancy, clinical project management and monitoring, biometrics, as well as medical safety and regulatory services.

SGS operates its own clinical pharmacology unit in Belgium featuring a viral challenge testing facility and a phase I patient unit based in Hungary. SGS has a wealth of expertise in FIH studies, viral challenge testing, biosimilars and complex PK/PD studies with a strong therapeutic focus on Infectious Diseases, Vaccines, Respiratory, Dermatology and Oncology.

Accreditations / Enablement

Partners are trained on the functionality of the Coder application, process optimization, and scope of Coder services. This Accreditation teaches Partners to integrate the medical coding solution with EDC studies and administer Coder segments. Coder Accreditation is dependent on the successful completion of the Rave EDC accreditation.
Partners are trained on the functionality of the eCOA application, best practices, process optimization and the scope of eCOA services. This Accreditation teaches Partners to process patient data that has been entered by the patient themselves, or by a Clinician. Patients enter their patient data through a provisioned device or their own device after downloading the appropriate app.  Clinicians enter patient data through a provisioned device (Android or iOS). eCOA Accreditation is dependent on the successful completion of the Rave EDC Accreditation.
Partners are trained on the functionality of the electronic data capture (EDC) and clinical data management (CDM) system, process optimization exercises and scope of Medidata Rave services. This Accreditation teaches the staff to perform end user training, user and site administration, study build, reporting, outputs and amendment manager.
Partners are trained on the functionality of the RTSM Application, process optimization, best practices using RTSM, and scope of RTSM services. This Accreditation teaches Partners to conduct randomization and clinical trial supply management services (RTSM). RTSM Accreditation is dependent on the successful completion of the Rave EDC Accreditation.
Partners are trained on the functionality of the targeted source document verification (TSDV) application, process optimization, and scope of TSDV services. This Accreditation teaches Partners to implement TSDV in line with regulatory compliance and data quality strategies. TSDV Accreditation is dependent on the successful completion of the Rave EDC Accreditation.